Vertex Pharmaceuticals Investor
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Investors
Technology:
AgeTech Companies, Cell-based gene therapy, Cell_Therapies, Stem cell therapy
Industry:
End-to-End Drug Development, Longevity Industry 2022, Public
Headquarters:
Boston, Massachusetts, United States
Founded Date:
1989-01-01
Employees Number:
1001-5000
Funding Status:
IPO
Investor Type:
Company
Investment Stage:
N/A
Number Of Exits:
2
Acquisitions Number:
Made Acquisitions
Investors Number:
9
Total Funding:
536197225
Estimated Revenue:
$500M to $1B
Last Funding Date:
2022-05-17
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership